Position in JNJ
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$7,744,815
+$108,510 QoQ
Shares Held
30,495
-2.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,275
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Procyon Advisors, LLC holds $38,982,476 across 11 Drug Manufacturers - General names. JNJ ranks #2 (19.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
32,392 | $8,151,122 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
30,495 | $7,744,815 | |
| 3 | LLY |
ELI LILLY & Co
|
6,408 | $7,685,948 | |
| 4 | MRK |
Merck & Co., Inc.
|
50,916 | $6,542,706 | |
| 5 | AMGN |
Amgen Inc
|
6,850 | $2,480,522 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
17,103 | $2,160,793 | |
| 7 | PFE |
Pfizer Inc
|
55,347 | $1,332,755 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,718 | $963,291 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,744,815 | 30,495 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $7,636,305 | 31,240 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $6,560,935 | 31,703 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $7,887,581 | 42,539 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $6,804,401 | 44,546 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $10,446,924 | 62,994 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $7,946,290 | 54,946 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $9,109,230 | 56,209 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $7,897,755 | 54,035 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $8,493,221 | 53,690 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $8,205,965 | 52,354 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $8,291,507 | 53,236 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $7,092,200 | 42,848 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $5,560,625 | 35,875 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $6,859,319 | 38,830 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $5,022,339 | 30,744 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $5,746,886 | 32,375 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $5,512,739 | 31,105 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $5,149,549 | 30,102 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $4,369,382 | 27,055 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $4,574,994 | 27,771 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $3,650,542 | 22,212 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $3,388,234 | 21,529 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $3,020,030 | 20,285 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $2,843,116 | 20,217 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,432,461 | 18,550 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||